Efflux of lipid from macrophages after induction of lipid accumulation by chylomicron remnants.

Biochim Biophys Acta

Department of Veterinary Basic Sciences, The Royal Veterinary College, Royal College Street, London NW1 0TU, UK.

Published: June 2005

The fate of cholesterol and triacylglycerol taken up and accumulated by macrophages after exposure to chylomicron remnants was investigated using macrophages derived from the human monocyte cell line THP-1 and chylomicron remnant-like particles containing human apolipoprotein (apo) E (CRLPs) as the experimental model. In THP-1 macrophages lipid loaded with CRLPs and incubated with various cholesterol acceptors for 24 h, the mass of cholesterol and cholesteryl ester found in the cells was not changed by HDL, HDL3 or lipid-free ApoA-I, although it was decreased by 38% by ApoA-I-phosphatidylcholine vesicles (ApoA-I-PC). After loading of the macrophages with [3H]cholesterol-labelled CRLPs, only about 5% of the label was effluxed in 24 h in the absence of cholesterol acceptors, and this increased to about 10% with ApoA-I or PC only, and to about 30% with apoA-I-PC. In similar experiments with [3H]triolein, only about 4% of the labelled triacylglycerol taken up by the cells was released into the medium in 24 h, and a large (>60%) and consistent proportion of the intracellular radioactivity remained associated with the triacylglycerol throughout this period. These results suggest that cholesterol and triacylglycerol derived from chylomicron remnants are not readily cleared from macrophages, and this is likely to contribute to the atherogenicity of the remnant lipoproteins.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbalip.2005.04.009DOI Listing

Publication Analysis

Top Keywords

chylomicron remnants
12
cholesterol triacylglycerol
8
cholesterol acceptors
8
macrophages
6
cholesterol
5
efflux lipid
4
lipid macrophages
4
macrophages induction
4
induction lipid
4
lipid accumulation
4

Similar Publications

Over 50% of patients who take statins are still at risk of developing atherosclerotic cardiovascular disease (ASCVD) and do not achieve their goal LDL-C levels. This residual risk is largely dependent on triglyceride-rich lipoproteins (TRL) and their remnants. In essence, remnant cholesterol-rich chylomicron (CM) and very-low-density lipoprotein (VLDL) particles play a role in atherogenesis.

View Article and Find Full Text PDF

Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study.

Arterioscler Thromb Vasc Biol

October 2024

Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Quebec, Canada (S.B., K.M.P., J.C., L.D., G.T., A.D.S.).

Background: Recent observational and Mendelian randomization analyses have reported significant effects of VLDL-C (very-low density lipoprotein cholesterol) on risk that is independent of ApoB (apolipoprotein B). We aim to determine the independent association of VLDL-C and ApoB with the risk of new onset cardiovascular events in the UK Biobank and Framingham Heart Study cohorts.

Methods: We included 294 289 UK Biobank participants with a median age of 56 years, 42% men, and 2865 Framingham Heart Study participants (median age, 53 years; 47% men).

View Article and Find Full Text PDF
Article Synopsis
  • Postprandial hypertriglyceridemia (PHTG) is linked to coronary heart disease due to the harmful buildup of chylomicron remnants (CM-Rs) and VLDL remnants (VLDL-Rs), with CM-Rs being less understood.
  • This study successfully isolated CM-Rs and VLDL-Rs from blood samples taken 3 hours after consuming high-fat meals using specialized antibodies and advanced proteomic analysis.
  • Key findings include the identification of 42 associated proteins—11 of which are newly discovered—highlighting specific proteins in CM-Rs that may contribute to their atherogenic nature, thus providing insights into their potential health risks.
View Article and Find Full Text PDF

The chylomicron saga: time to focus on postprandial metabolism.

Front Endocrinol (Lausanne)

February 2024

Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California, Vallejo, CA, United States.

Since statins have had such tremendous therapeutic success over the last three decades, the field of atherosclerosis has become somewhat LDL-centric, dismissing the relevance of triglycerides (TG), particularly chylomicrons, in atherogenesis. Nonetheless, 50% of patients who take statins are at risk of developing atherosclerotic cardiovascular disease (ASCVD) and are unable to achieve their goal LDL-C levels. This residual risk is mediated, in part by triglyceride rich lipoproteins (TRL) and their remnants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!